The proton pump inhibitor lansoprazole, but not rabeprazole, the increased blood concentrations of calcineurin inhibitors in Japanese patients with connective tissue diseases. [electronic resource]
- Internal medicine (Tokyo, Japan) 2014
- 1413-8 p. digital
Publication Type: Journal Article
1349-7235
10.2169/internalmedicine.53.2394 doi
Calcineurin Inhibitors--blood Connective Tissue Diseases--blood Cyclosporine--blood Cytochrome P-450 CYP2C19--genetics Drug Interactions Female Gastrointestinal Diseases--blood Genotype Humans Lansoprazole--therapeutic use Male Middle Aged Polymorphism, Genetic Proton Pump Inhibitors--therapeutic use Rabeprazole--therapeutic use Retrospective Studies Tacrolimus--blood